The Conversation (0)
MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results
Feb. 28, 2018 08:57AM PST
Pharmaceutical InvestingMannKind (NASDAQ:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2017. As quoted in the press release: For the fourth quarter of 2017, Afrezza net revenue was $4.5 million, an increase of 125% compared to the third quarter of 2017 and 238% compared to the fourth quarter of 2016. Included in …
MannKind (NASDAQ:MNKD) today reported financial results for the fourth quarter and full year ended December 31, 2017.
As quoted in the press release:
For the fourth quarter of 2017, Afrezza net revenue was $4.5 million, an increase of 125% compared to the third quarter of 2017 and 238% compared to the fourth quarter of 2016. Included in the fourth quarter net revenue is a favorable adjustment for a change in estimate of $1.4 million. The change in estimate relates to obtaining new and more comprehensive data regarding the inventory in the distribution channel – specifically inventory in the retail channel.